The Risky Business of Experimental Peptides
Business owners and politicians are lobbying regulators for easier access to new injectable drugs against the recommendations of some medical experts. But customer demand isn’t waning.
We haven't written up this one. Business of Fashion has the full story — the link below goes straight to it.